Alnylam Pharmaceuticals I... (ALNY)

AI Score

Unlock

241.97

5.22 (2.20%)

At close: Apr 23, 2025, 3:59 PM

241.89

-0.03%

Pre-market: Apr 24, 2025, 04:23 AM EDT

Alnylam Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	2.25B	1.83B	1.04B	844.29M	492.85M	219.75M	74.91M	89.91M	47.16M
Cost of Revenue	323.37M	310.41M	168.82M	140.14M	78.05M	25.06M	1.8M	13.37M	n/a
Gross Profit	1.92B	1.52B	868.6M	704.14M	414.8M	194.69M	73.11M	76.55M	47.16M
Operating Income	-176.88M	-282.18M	-785.07M	-708.65M	-828.44M	-939.43M	-814.67M	-500.09M	-424.59M
Interest Income	121.99M	95.56M	24.81M	1.58M	11.81M	33.45M	29.26M	12.24M	8.31M
Pretax Income	-178.94M	-433.52M	-1.13B	-852.14M	-855.6M	-885.25M	-760.67M	-490.87M	-410.11M
Net Income	-278.16M	-440.24M	-1.13B	-852.82M	-858.28M	-886.12M	-761.5M	-490.87M	-410.11M
Selling & General & Admin	975.53M	795.65M	770.66M	620.64M	588.42M	479M	382.36M	199.37M	89.35M
Research & Development	1.13B	1B	883.01M	792.16M	654.82M	655.11M	505.42M	390.63M	382.39M
Other Expenses	n/a	n/a	-109.37M	-2.05M	45.52M	20.73M	4.17M	-3.02M	6.17M
Operating Expenses	2.1B	1.8B	1.65B	1.41B	1.24B	1.13B	887.78M	590M	471.75M
Interest Expense	141.86M	121.22M	155.97M	143.02M	84.5M	n/a	29.26M	12.24M	8.31M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	2.43B	2.11B	1.82B	1.55B	1.32B	1.16B	889.58M	590M	471.75M
Income Tax Expense	99.22M	6.72M	4.16M	680K	2.68M	863K	823K	-25.6M	-23.44M
Shares Outstanding (Basic)	128.59M	124.91M	121.69M	118.45M	114.99M	109.26M	100.59M	90.55M	85.6M
Shares Outstanding (Diluted)	128.59M	124.91M	121.69M	118.45M	114.99M	109.26M	100.59M	90.55M	85.6M
EPS (Basic)	-2.16	-3.52	-9.3	-7.2	-7.46	-8.11	-7.57	-5.42	-4.79
EPS (Diluted)	-2.16	-3.52	-9.3	-7.2	-7.46	-8.11	-7.57	-5.42	-4.79
EBITDA	-178.85M	-258.24M	-926.56M	-661.56M	-736.33M	-868.08M	-754.24M	-488.19M	-409.46M
EBIT	-235.52M	-312.3M	-971.02M	-709.12M	-771.1M	-885.25M	-760.67M	-500.09M	-424.59M
Depreciation & Amortization	56.67M	54.05M	44.47M	47.57M	34.77M	17.18M	6.43M	13.37M	15.13M